Replacing refined grains with whole grains lowers all-cause mortality by 17% and coronary heart disease by 19%, while refined grains offer no protective benefit (archive interpretation of Aune 2016).
Original statement
ظهر أن استبدال الحبوب المكررة بالكاملة يخفض الوفاة لأي سبب بنسبة 17٪ وأمراض القلب التاجية بنسبة 19٪، بينما لم تظهر الحبوب المكررة أي فائدة وقائية على الإطلاق.
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
Replacing refined grains with whole grains lowers all-cause mortality by 17% and coronary heart disease by 19%, while refined grains offer no protective benefit (archive interpretation of Aune 2016).
Origin
- Source status
- Archive editors
- Attribution
- Archive editors (study selection and narrative)
- Origin
- https://eltayebat.com/rule/refined-wheat/
- Attribution uncertainty
- Written by the archive operators; the study citations are the archive's, not shown to be Elawady's own.
- Claimed mechanism
Fibre, bran and germ removed by milling.
- Claimed health effect
Lower mortality and CHD with whole grains.
- Population concerned
General population.
- Geographic restriction by Elawady
none found
Scientific assessment
Mostly true – Correct at its core, but with limitations or minor inaccuracies.
Certainty of evidence: moderate – Further research may still affect the assessment.
1. What was claimed?
Whole grains instead of refined grains reduce death and CHD.
2. What is demonstrably correct?
Per 90 g/day whole grain: CHD RR 0.81 (0.75-0.87), CVD 0.78 (0.73-0.85), all-cause mortality 0.83 (0.77-0.90) (A-WHT-02). Reynolds 2019 found similar benefits for whole grain and fibre (I-WHT-01).
3. What is wrong or exaggerated?
The study did not model 'swapping': all estimates are per 90 g/day increment of whole grain. It also found 'little evidence of an association' for refined grains - meaning no harm, and in some dose-response analyses even weak inverse associations with total cancer and mortality - which the archive presents as one-sided. Observational associations are presented as effects ('cut').
4. What remains unclear?
Size of benefit attributable to whole grain itself versus healthier lifestyle of whole-grain eaters; short RCTs show modest effects on risk factors.
5. Which studies support it?
A-WHT-02, I-WHT-01, A-WHT-13, A-WHT-04.
6. Which studies contradict it?
None against the direction; limitations as above.
7. What applies to Germany and Europe?
Consistent with DGE and EU dietary guidance to prefer whole-grain products.
8. What is known about Egypt?
Whole-grain options (freekeh, whole-wheat bread, whole maize) are available; consistent with the system's allowance of freekeh and corn.
9. What practical conclusion is appropriate?
Prefer whole grains. This supports part of the system's direction, though not its mechanism.
Assessment details
- Rationale for certainty of evidence
Whole-grain intake is consistently associated with lower CHD, CVD and mortality in prospective cohorts (A-WHT-02) and in the WHO-commissioned Lancet review (I-WHT-01; GRADE low to moderate for whole grains, moderate for fibre). Downgraded because the archive misstates the analysis: the 17%/19% figures are per 90 g/day increase in whole grain, not a substitution analysis, and the data are observational.
- Source quality
A-WHT-02 is a high-quality dose-response meta-analysis; the archive's paraphrase ('swapping') is inaccurate.
- Regional transferability
Mostly US/European cohorts; direction likely transferable.
- Individual exceptions
People with coeliac disease must use gluten-free whole grains.
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 25 October 2026 provisional
In plain language
Large reviews show that people who eat more whole grains, such as whole-wheat bread or freekeh, have fewer heart problems and live longer on average. The archive turns this into a precise promise ('swapping lowers death by 17%'), which the study did not test. The general advice to prefer whole grains is well supported. It does not prove that normal amounts of white bread are harmful.
Studies on this claim
Studies supporting the claim (3)
-
Whole grains and lower risk of heart disease and death
Aune D et al.. BMJ 2016 · PMID 27301975 · DOI 10.1136/bmj.i2716Meta-analysiscited by the Tayebat archivefull text checked★ key studyEach 3 servings/day of whole grains linked to 17% lower mortality and 19% lower CHD.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Summarise studies on whole grains and disease
- How was the study done?
Dose-response meta-analysis
- How many people, animals or samples were studied?
45 cohort studies; up to about 705,000 participants and 100,726 deaths (all-cause mortality analysis).
- What was actually found?
Whole grains linked to less disease; refined grains neutral
- How large was the observed effect?
RR 0.83 mortality per 90 g/day
- What do the results mean in everyday life?
Choosing whole grains is linked to better health
- What are the study's limitations?
Observational data; high heterogeneity for total mortality; no registered protocol; substitution not studied.
- What does it say about Elawady's specific claim?
Supports whole-grain preference, not 'white flour is poison'
- Do the results apply to Germany and Europe?
Applicable
- What can explicitly not be concluded from this study?
Cannot prove cause, cannot quantify the effect of swapping refined for whole grains, and shows no harm from refined grains.
-
Fibre and whole grains and health
Reynolds A et al.. Lancet 2019 · PMID 30638909 · DOI 10.1016/S0140-6736(18)31809-9Meta-analysisindependent cross-checkabstract only checked★ key studyHigh fibre/whole grain intake linked to 15-30% lower risk of several diseases; GI/GL evidence weaker.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Carbohydrate quality
- How was the study done?
Systematic reviews with GRADE
- How many people, animals or samples were studied?
185 cohorts, 58 trials
- What was actually found?
Fibre and whole grain protective
- How large was the observed effect?
15-30% lower risk
- What do the results mean in everyday life?
Eat more fibre and whole grains
- What are the study's limitations?
Observational core
- What does it say about Elawady's specific claim?
Supports whole grains, not glue mechanism; GI/GL arguments weak
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Harm from moderate refined grains
-
Whole grain and bran and diabetes
de Munter JS et al.. PLoS Med 2007 · PMID 17760498 · DOI 10.1371/journal.pmed.0040261Cohort studycited by the Tayebat archiveabstract only checkedHighest whole grain intake: about 25-37% lower diabetes risk.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Whole grain and diabetes
- How was the study done?
Cohort + meta-analysis
- How many people, animals or samples were studied?
286,125
- What was actually found?
Inverse association
- How large was the observed effect?
21% per 2 servings
- What do the results mean in everyday life?
Whole grain helpful
- What are the study's limitations?
Observational
- What does it say about Elawady's specific claim?
Supports whole grains
- Do the results apply to Germany and Europe?
Moderate
- What can explicitly not be concluded from this study?
Cause
No study in this group is marked as key.
Studies contradicting or limiting the claim (0)
No studies in this group.
Studies with mixed or unclear results (1)
-
Refined grains and heart disease (industry-linked author)
Gaesser GA. Trends Cardiovasc Med 2024 · PMID 36075506 · DOI 10.1016/j.tcm.2022.08.002Meta-analysisindependent cross-checkabstract only checkedPooled cohorts showed no clear link between refined grains and heart disease.
Does the study support the specific claim? No · Methodological quality: low · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Refined grains and CVD
- How was the study done?
Meta-analysis
- How many people, animals or samples were studied?
17 cohorts
- What was actually found?
No association
- How large was the observed effect?
HR 1.08 (ns)
- What do the results mean in everyday life?
Moderate refined grains not clearly harmful
- What are the study's limitations?
COI, heterogeneity
- What does it say about Elawady's specific claim?
Limits harm claim
- Do the results apply to Germany and Europe?
Moderate
- What can explicitly not be concluded from this study?
Benefit of refined grains
No study in this group is marked as key.
Regional context
Germany / EU
Consistent with DGE and EU dietary guidance to prefer whole-grain products.
Egypt
Whole-grain options (freekeh, whole-wheat bread, whole maize) are available; consistent with the system's allowance of freekeh and corn.
What applies in my country?
General scientific assessment
Mostly true Whole grains are associated with clear health benefits; the archive overstates the precision and causality of the numbers.
The following areas of food safety are relevant to this statement:
- Pesticides and pesticide residues
- Contaminants (heavy metals, PFAS, PCBs, dioxins, nitrate)
- Mycotoxins (mould toxins)
Cereals and rice
Choose a country to see the checked information for it.
Limits: legal rules describe what is allowed, not what every single food contains. Measurement data come from samples and are meaningful only together with their method details.
Country of residence or purchase Compare with another country
References
- Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies.. Aune D et al.. BMJ 2016 · PMID 27301975 · DOI 10.1136/bmj.i2716
- Carbohydrate quality and human health: a series of systematic reviews and meta-analyses.. Reynolds A et al.. Lancet 2019 · PMID 30638909 · DOI 10.1016/S0140-6736(18)31809-9
- Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review.. de Munter JS et al.. PLoS Med 2007 · PMID 17760498 · DOI 10.1371/journal.pmed.0040261
- Refined grain intake and cardiovascular disease: Meta-analyses of prospective cohort studies.. Gaesser GA. Trends Cardiovasc Med 2024 · PMID 36075506 · DOI 10.1016/j.tcm.2022.08.002